Followers | 241 |
Posts | 12120 |
Boards Moderated | 3 |
Alias Born | 04/05/2009 |
Friday, July 24, 2015 11:51:22 PM
By Kelly Knaub
Law360, New York (July 17, 2015, 7:57 PM ET) -- Southeast Georgia Health System hit Becton Dickinson and Co. with a putative class action in Georgia federal court Friday, accusing the medical technology company of pushing competitors making safer needles out of the hypodermic syringes market.
The hospital alleges that despite federal law mandating practices to reduce dangerous needlestick injuries from conventional syringes since 2001 — injuries nurses experience more than 600,000 times annually, the suit says — New Jersey-based BD has slowly made only minor and ineffective changes to its conventional syringes, failing to reduce needlesticks and in some cases dramatically increasing them.
Southeast Georgia says that instead of competing and improving upon the technology put forth by Retractable Technologies Inc., which sells patented syringes that reduce needlesticks to a minimum and have been given the highest safety rating by a prominent testing laboratory, BD has suppressed competition and maintained its monopoly through a variety of schemes.
“Rather than compete, and meet and improve upon Retractable’s innovation on the merits using its vast resources to protect the national health, Becton has taken the low road of the repetitive antitrust scofflaw,” the hospital says.
BD is suppressing competition through, for example, exclusionary bundled rebates that foreclose acute care providers from effective competitive access to safer syringes; penalty contracts and sole-source contracts that achieve the same end; theft of Retractable’s innovative technology to use it against Retractable and greatly impede its market entry; six years of competitive deception and false advertising; and the elimination of a significant safety rival by acquisition, according to the suit.
BD is also using many of the same schemes to obtain and maintain a monopoly in the market for the sale of IV catheters to acute care providers, the complaint claims.
Southeast Georgia’s complaint brings one count of syringe monopolization and one count of IV catheter monopolization, both brought under Section 2 of the Sherman Act.
The hospital said it seeks to represent proposed classes of thousands of acute care providers purchasing syringes and IV catheters under cost-plus distribution contracts.
In August 2013, BD struck a $22 million settlement with hospitals and pharmacies whose class actions accused the company of stifling competition from other hypodermic product makers.
And earlier this year, Retractable claimed it deserved $5.65 million in prejudgment interest in a false advertising and antitrust suit it brought against BD — on top of the $340 million it won — but a Texas federal judge instead granted BD’s bid to vacate the prejudgment interest.
A BD representative did not immediately return a request for comment.
Southeast Georgia is represented by Wallace E. Harrell and Mark D. Johnson of Gilbert Harrell Sumerford & Martin PC and R. Stephen Berry of Berry Law PLLC.
Counsel information for Becton Dickinson was not immediately available.
The case is Glynn-Brunswick Hospital Authority et al. v. Becton Dickinson and Co., case number 2:15-cv-00091, in the U.S. District Court for the Southern District of Georgia.
http://www.law360.com/articles/680556/becton-sued-for-squeezing-out-rivals-with-safer-syringes
"Someone said it takes 30 years to be an instant success" - Gabriel Barbier-Mueller, CEO of Harwood International
Recent BDX News
- BD Celebrates 75 years of U.S. Manufacturing Excellence in Nebraska • PR Newswire (US) • 08/22/2024 05:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 03:23:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 03:21:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2024 05:47:05 PM
- BD Names Michael Feld as President of Life Sciences Segment • PR Newswire (US) • 08/12/2024 10:50:00 AM
- BD to Present at Wells Fargo 2024 Healthcare Conference • PR Newswire (US) • 08/08/2024 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 07:53:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 07:51:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:33:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 10:32:40 AM
- BD Reports Third Quarter Fiscal 2024 Financial Results • PR Newswire (US) • 08/01/2024 10:30:00 AM
- BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases • PR Newswire (US) • 07/25/2024 10:45:00 AM
- BD Board Declares Dividend • PR Newswire (US) • 07/23/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 10:01:14 AM
- Costco Hikes Membership Fees; ON Semiconductor Stock Drops 3%; WD-40 Soars 13% on Strong Q3 Earnings • IH Market News • 07/11/2024 10:17:26 AM
- BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials • PR Newswire (US) • 07/10/2024 04:12:00 PM
- BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023 • PR Newswire (US) • 07/10/2024 10:50:00 AM
- BD to Announce Financial Results for its Third Quarter of Fiscal 2024 • PR Newswire (US) • 07/03/2024 12:30:00 PM
- New BD Research Tool Helps Scientists Study Cells that are Often Key Culprits in the Development of Cancer and Infectious Diseases • PR Newswire (US) • 06/26/2024 10:45:00 AM
- BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts • PR Newswire (US) • 06/20/2024 12:30:00 PM
- Form 8-A12B - Registration of securities [Section 12(b)] • Edgar (US Regulatory) • 06/12/2024 12:45:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 05:45:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/10/2024 08:59:53 PM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM